Skip to search formSkip to main contentSkip to account menu

SEC23B gene

Known as: HEMPAS, CDAII, SEC23B 
This gene plays a role in vesicular transport.
National Institutes of Health

Related topics

Related topics

10 relations
Congenital dyserythropoietic anemiaCongenital dyserythropoietic anemia, type IIHomo sapiensIntracellular Transport

Broader (1)

Genes

Narrower (1)

SEC23B wt Allele

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Non-myeloablative allogeneic stem cell transplant with post-transplant cyclophosphamide cures the first adult patient with congenital dyserythropoietic anemia
Non-myeloablative allogeneic stem cell transplant with post-transplant cyclophosphamide cures the first adult patient with… 
2016
2016
Peripheral marginalisation of endoplasmic reticulum membranes in cultured erythroblasts of congenital dyserythropoietic anaemia type II
Congenital dyserythropoietic anaemia type II (CDAII, MIM 224100) is an autosomal recessive disorder of the bone marrow resulting… 
Review
2013
Review
2013
[Congenital dyserythropoietic anemia type II with novel mutations in SEC23B and HFE2 genes: a Chinese family survey].
OBJECTIVE To report novel mutations SEC23B gene in congenital dyserythropoietic anemia (CDA). METHODS By direct sequencing… 
2011
2011
Two founder mutations in the SEC23B gene account for the relatively high frequency of CDA II in the Italian population
Congenital Dyserythropoietic Anemia type II is an autosomal recessive disorder characterized by unique abnormalities in the… 
2011
2011
E109K Is a SEC23B Founder Mutation among Israeli Moroccan Jewish Patients with Congenital Dyserythropoietic Anemia Type II
Objective: Congenital dyserythropoietic anemia (CDA) is characterized by ineffective erythropoiesis, binuclearity of erythroid… 
Review
2010
Review
2010
Plucking, pillaging and plundering proteomes with combinatorial peptide ligand libraries.
2009
2009
Remission from transfusion‐dependence in a patient with congenital dyserythropoietic anemia (CDA) and increased intensity of iron chelation
To the Editor: Transfusion-dependent congenital dyserythropoietic anemias (CDAs) are not generally thought of as amenable to… 
Highly Cited
1984
Highly Cited
1984
Defect in glycosylation of erythrocyte membrane proteins in congenital dyserythropoietic anaemia type II (HEMPAS)
Summary Congenital dyserythropoietic anaemia type II (HEMPAS) is a hereditary disease believed to be caused by a membrane… 
Review
1973
Review
1973
HEMPAS.
An important mechanism of anaemia is reduced production of red cells by the bone marrow. This can be due to a reduction in the… 
Review
1972
Review
1972
Red‐Cell Abnormalities in HEMPAS (Hereditary Erythroblastic Multinuclearity with a Positive Acidified‐Serum Test)
Summary. Abnormalities of the membrane of HEMPAS red cells have been demonstrated by certain serological tests and in freeze‐etch… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)